Literature DB >> 16018996

[3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction.

Christian Wolff1, Michel Gillard, Bruno Fuks, Pierre Chatelain.   

Abstract

Linopirdine was developed as a cognitive enhancing molecule and demonstrated to specifically block the potassium current generated by the brain specific KCNQ2-KCNQ3 proteins (M-channel). In this study we investigated the relevance of [(3)H]linopirdine binding in rat brain extracts to the interaction with the M-channel proteins. Our results confirm the presence of a high affinity site for [(3)H]linopirdine in rat brain tissues (KD = 10 nM) but we also identified a high affinity binding site for [(3)H]linopirdine in rat liver tissues (KD = 9 nM). Competition experiments showed that [(3)H]linopirdine is displaced by unlabelled linopirdine with comparable affinities from its binding sites on rat brain and rat liver membranes. [(3)H]linopirdine was completely displaced by a set of cytochrome P450 (CYP450) ligands suggesting that [(3)H]linopirdine binding to rat brain and liver membranes is linked to CYP450 interaction. The testing of CYP450 ligands on the M-channel activity, using a Rb(+) efflux assay on cells expressing the KCNQ2-KCNQ3 proteins, demonstrated that [(3)H]linopirdine binding results cannot be correlated to M-channel inhibition. The results obtained in this study demonstrate that [(3)H]linopirdine binding to rat brain and rat liver membranes is representative for CYP450 interaction and not relevant for the binding to the M-channel proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018996     DOI: 10.1016/j.ejphar.2005.06.005

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission.

Authors:  Jianli Sun; Jaideep Kapur
Journal:  J Physiol       Date:  2012-06-06       Impact factor: 5.182

2.  Drug binding assays do not reveal specific binding of lacosamide to collapsin response mediator protein 2 (CRMP-2).

Authors:  Christian Wolff; Bruce Carrington; Michel Varrin-Doyer; Anne Vandendriessche; Christy Van der Perren; Michel Famelart; Michel Gillard; Patrik Foerch; Véronique Rogemond; Jerôme Honnorat; Alastair Lawson; Karen Miller
Journal:  CNS Neurosci Ther       Date:  2012-06       Impact factor: 5.243

3.  Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells.

Authors:  Di-Ling Chen; Peng Zhang; Li Lin; Ou Shuai; He-Ming Zhang; Song-Hao Liu; Jin-Yu Wang
Journal:  Cell Mol Neurobiol       Date:  2013-06-29       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.